CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- S-3MEF Other S-3MEF
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale 10% owner sold 41,803 shares at an average $25.07 ($1,047,876)
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale 10% owner sold 10,898 shares at an average $25.01 ($272,511)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- 20-F/A Report Annual and Transition Report of Foreign Private Issuers
- 8-K Event Restatement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Accounting Officer sold 45,000 shares at $15.72 ($707,400)
- 144 Insider Sale of Securities
Page 11 of 21 · 415 filings